Regulation of Medicines of Biological Origin in Colombia: an Analysis from Bioethics and Law

The general objective of the project is to determine whether the CAN policy and that of each of the member countries is consistent with each other and with WHO guidelines and allows users of health systems real and effective access to high-cost medicines as mechanisms for achieving the right to the highest standards and quality of health in the region.

In order to achieve this objective, specific objectives are proposed: 1) Establish the CAN regulatory framework and the internal regulations of the member countries regarding access to high-cost medicines; 2) Conduct an analysis of the pharmaceutical market in each of the countries of the Andean Community of Nations; 3) Identify the population's internal judicial instruments for access to high-cost medicines in the context of each of their health systems in order to evaluate their impact in relation to the supply of high-cost medicines; 4) Determine the rights involved in contrasting the intellectual property rights of the pharmaceutical industry with the rights of users of the health systems of the CAN countries; and, 5) Contribute to the debate and construction of a policy for regulating access to medicines through collaborative work between academia and institutional bodies.

Artículos de investigación